Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder

Comprehensive Psychiatry

Volumn 52, Issue 5, 2011, Pages 556-561

  Besiroglu, Lutfullah ^a   Çetinkaya, Nuralay ^b   Selvi, Yavuz ^a   Atli, Abdullah ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b Erzurum State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT TOOL; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; METACOGNITION; METACOGNITIONS QUESTIONNAIRE; MORALITY; OBSESSIVE COMPULSIVE DISORDER; PSYCHOLOGIC TEST; THOUGHT ACTION FUSION; THOUGHT ACTION FUSION SCALE; THOUGHT SUPPRESSION; WHITE BEAR SUPPRESSION INVENTORY; YALE BROWN OBSESSIVE COMPULSIVE SCALE,;

ADULT; COGNITION; COMORBIDITY; DEPRESSION; FEMALE; FLUOXETINE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEVERITY OF ILLNESS INDEX; THINKING; TREATMENT OUTCOME;

EID: 80051908552     PISSN: 0010440X     EISSN: 15328384     Source Type: Journal    
DOI: 10.1016/j.comppsych.2010.10.003     Document Type: Article

References (38)

1. Purdon C., and Clark D.A. Obsessive intrusive thoughts in nonclinical subjects. Part 1. Content and relation with depressive, anxious and obsessional symptoms Behav Res Ther 31 1993 713 720 (Pubitemid 23296865)
2. Purdon C. Empirical investigations of thought suppression J Behav Ther Exp Psychiatry 35 2004 121 136
3. Rassin E., Diepstraten P., Merckelbach H., and Muris P. Thought-action fusion and thought suppression in obsessive-compulsive disorder Behav Res Ther 39 2001 757 764 (Pubitemid 32510705)
4. Wenzlaff R.M., and Wegner D.M. Thought suppression Annu Rev Psychol 51 2000 59 91
5. Shafran R., Thordarson D., and Rachman S. Thought-action fusion in obsessive compulsive disorder J Anxiety Disord 10 1996 379 391 (Pubitemid 26329070)
6. Purdon C., and Clark D.A. Metacognition and obsessions Clin Psychol Psychother 6 1999 96 101
7. Wells A., and Papageorgiou C. Relationships between worry, obsessive-compulsive symptoms and meta-cognitive beliefs Behav Res Ther 36 1997 899 913 (Pubitemid 28377136)
8. O'Connor K.P., Aardema F., Robillard S., Guay S., Pélissier M.C., and Todorov C. Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder Acta Psychiatr Scand 113 2006 408 419
9. Whittal M.L., Thordarson D.S., and McLean P.D. Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs. exposure and response prevention Behav Res Ther 43 2005 1559 1576 (Pubitemid 41464360)
10. Solem S., Håland A.T., Vogel P.A., Hansen B., and Wells A. Change in metacognitions predicts outcome in obsessive-compulsive disorder patients undergoing treatment with exposure and response prevention Behav Res Ther 47 2009 301 307
11. Alonso P., Menchon J.M., Pifarre J., Mataix-Cols D., Torres L., and Salgado P. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy J Clin Psychiatry 62 2001 535 540 (Pubitemid 32703093)
12. Baldwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Bond A., and Davidson J.R. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol 19 2005 567 596 (Pubitemid 41578819)
13. Bandelow B., Zohar J., Hollander E., Kasper S., and Moller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders World J Biol Psychiatry 3 2002 171 199
14. First M.B., Gibbon M., Spitzer R.L., and Williams J.B.W. User's guide for the Structured Clinical Interview for DSM-IV Axis I disorders-Research Version (SCID-I, version 2.0, February 1996 final version) 1996 Biometrics Research Department, Psychiatric Institute New York, NY
15. Guy W. M.D. Rockville, ECDU assessment manual for psychopharmacology, revised 1976 National Institute of Mental Health, Department of Health Education and Welfare Publication, ADM Rockville, MD 76 338
16. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., and Hill C.L. The Yale-Brown Obsessive Compulsive Scale, I: development, use and reliability Arch Gen Psychiatry 46 1989 1006 1011 (Pubitemid 19278229)
17. Beck A.T., Steer R.A., and Garbin M.C. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation Clin Psychol Rev 8 1988 77 100 (Pubitemid 18045797)
18. Wells A., and Cartwright-Hatton S. A short form of the metacognitions questionnaire: properties of the MCQ-30 Behav Res Ther 42 2004 385 396 (Pubitemid 38283820)
19. Wegner D.M., and Zanakos S. Chronic thought suppression J Pers 62 1994 615 640
20. Tek C., Ulug B., Rezaki B.G., Tanriverdi N., Mercan S., and Demir B. Yale-Brown Obsessive Compulsive Scale and US National Institute of Mental Health Global Obsessive Compulsive Scale in Turkish: reliability and validity Acta Psychiatr Scand 91 1995 410 413
21. Hisli N. Beck depresyon envanteri'nin geçerliligi üzerine bir çalIşma Psikol Derg 6 1988 118 122
22. Yorulmaz O., Yilmaz A.E., and Gencoz T. Psychometric properties of the thought-action fusion scale in a Turkish sample Behav Res Ther 42 2004 1203 1214 (Pubitemid 39179913)
23. Tosun A., and Irak M. Adaptation, validity, and reliability of the Metacognition Questionnaire-30 for the Turkish population, and its relationship to anxiety and obsessive-compulsive symptoms Türk Psikiyatri Derg 19 2008 67 80
24. Agargun M.Y., Beşiroǧlu L., KIran U.K., Kara H., and Ozer O.A. The reliability and validity of the White Bear Suppression Inventory Türk Psikiyatri Derg 15 2004 282 290
25. Denys D., Femke de Geus M.A., Van Megen H.G.J.M., and Westenberg H.G. A double blind, randomized, placebo-controlled trial of quetiapine in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors J Clin Psychiatry 65 2004 1040 1048
26. Overbeek T., Schruers K., Vermetten E., and Griez E. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect J Clin Psychiatry 63 2002 1106 1112 (Pubitemid 36084054)
27. Uguz F., Askin R., Cilli A.S., and Besiroglu L. Comparison of treatment responses and clinical characteristics of early-onset and late-onset obsessive-compulsive disorder Int J Psychiatry Clin Pract 10 2006 291 296 (Pubitemid 44721772)
28. Greist J., Chouinard E., DuBoff A., DuBoff A., Halaris S.W., and Kim L. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder Arch Gen Psychiatry 52 1995 289 295
29. Tollefson A., Rampey J., Potvin M.A., Jenike A.J., Rush R.A., and Dominguez L.M. A multi-center investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder Arch Gen Psychiatry 51 1994 559 567 (Pubitemid 24211033)
30. Wenzlaff R.M., Wegner D.M., and Klein S.B. The role of thought suppression in the bonding of thought and mood J Pers Soc Psychol 60 1991 500 508
31. Salkovskis P. Obsessional-compulsive problems: a cognitive-behavioural analysis Behav Res Ther 23 1985 571 583 (Pubitemid 15014280)
32. Spinella M. Mood in relation to subclinical obsessive-compulsive symptoms Int J Neurosci 115 2005 433 443 (Pubitemid 40460677)
33. Tükel R., Polat A., Özdemir Ö., Aksüt D., and Türksoy N. Comorbid conditions in obsessive-compulsive disorder Compr Psychiatry 43 2002 204 209 (Pubitemid 34507468)
34. Montgomery S.A. Psychopharmacology of obsessive compulsive disorder CNS Spectr 3 Suppl 1 1998 33 37
35. Mansell W., Harvey A., Watkins E., and Shafran R. Conceptual foundations of the transdiagnostic approach to CBT J Cogn Psychother 23 2009 6 19
36. Besiroglu L., Uguz F., Ozbebit O., Guler O., Cilli A.S., and Askin R. Longitudinal assessment of symptom and subtype categories in obsessive-compulsive disorder Depress Anxiety 247 2007 461 466 (Pubitemid 350086258)
37. Rowa K., Purdon C., Summerfeldt L.J., and Antony M.M. Why are some obsessions more upsetting than others? Behav Res Ther 43 2005 1453 1465 (Pubitemid 41278533)
38. Brody A.L., Saxena S., Fairbanks L.A., Alborzian S., Demaree H.A., and Maidment K.M. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine J Clin Psychiatry 61 2000 349 355 (Pubitemid 30345936)